Cargando…
Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
Hydralazine and nitrate combination was the first treatment that showed improved survival of patients with heart failure with reduced left ventricular ejection fraction (HFREF) in the Vasodilator Heart Failure Trial (V‐HeFT trial) in 1986. This showed a 34% reduction of mortality at 2 years of follo...
Autor principal: | Al‐Mohammad, Abdallah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676279/ https://www.ncbi.nlm.nih.gov/pubmed/31119890 http://dx.doi.org/10.1002/ehf2.12459 |
Ejemplares similares
-
The Role of Cardiac Imaging in Heart Failure with Reduced Ejection Fraction
por: Gosling, Rebecca C, et al.
Publicado: (2022) -
Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and
Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection
Fraction
por: Golwala, Harsh B., et al.
Publicado: (2013) -
Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction
por: Zamani, Payman, et al.
Publicado: (2017) -
Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a “2‐Hit” Murine Model
por: LaPenna, Kyle B., et al.
Publicado: (2023) -
Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)